2024-03-28T21:54:47Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_119D11D55F85
2024-03-23T01:51:56Z
serval:BIB_119D11D55F85
PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study.
10.1007/s00428-019-02582-0
000474496100007
31127385
Savic
S.
author
Berezowska
S.
author
Eppenberger-Castori
S.
author
Cathomas
G.
author
Diebold
J.
author
Fleischmann
A.
author
Jochum
W.
author
Komminoth
P.
author
McKee
T.
author
Letovanec
I.
author
Jasarevic
Z.
author
Rössle
M.
author
Singer
G.
author
von Gunten
M.
author
Zettl
A.
author
Zweifel
R.
author
Soltermann
A.
author
Bubendorf
L.
author
article
2019-07
Virchows Archiv
1432-2307
0945-6317
journal
475
1
67-76
Antibodies/immunology
Automation, Laboratory
B7-H1 Antigen/analysis
Biomarkers, Tumor/analysis
Carcinoma, Non-Small-Cell Lung/chemistry
Carcinoma, Non-Small-Cell Lung/immunology
Carcinoma, Non-Small-Cell Lung/pathology
Humans
Immunohistochemistry/instrumentation
Immunohistochemistry/methods
Immunohistochemistry/standards
Lung Neoplasms/chemistry
Lung Neoplasms/immunology
Lung Neoplasms/pathology
Observer Variation
Predictive Value of Tests
Reproducibility of Results
Switzerland
Tissue Array Analysis
22C3
Immunohistochemistry
Non-small cell lung carcinoma
PD-L1
SP263
eng
60_published
peer-reviewed
Publication types: Comparative Study ; Journal Article ; Multicenter Study ; Validation Studies
Publication Status: ppublish